KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $7.3 billion.

  • Eli Lilly's Cash & Current Investments rose 11234.08% to $7.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.3 billion, marking a year-over-year increase of 11234.08%. This contributed to the annual value of $7.3 billion for FY2025, which is 11234.08% up from last year.
  • Per Eli Lilly's latest filing, its Cash & Current Investments stood at $7.3 billion for Q4 2025, which was up 11234.08% from $9.9 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Cash & Current Investments registered a high of $9.9 billion during Q3 2025, and its lowest value of $2.2 billion during Q4 2022.
  • Moreover, its 5-year median value for Cash & Current Investments was $3.2 billion (2021), whereas its average is $3.7 billion.
  • In the last 5 years, Eli Lilly's Cash & Current Investments crashed by 4341.2% in 2022 and then soared by 18176.16% in 2025.
  • Over the past 5 years, Eli Lilly's Cash & Current Investments (Quarter) stood at $3.9 billion in 2021, then crashed by 43.41% to $2.2 billion in 2022, then skyrocketed by 32.37% to $2.9 billion in 2023, then rose by 16.91% to $3.4 billion in 2024, then surged by 112.34% to $7.3 billion in 2025.
  • Its Cash & Current Investments stands at $7.3 billion for Q4 2025, versus $9.9 billion for Q3 2025 and $3.5 billion for Q2 2025.